Carlson Laboratories Reacts to Recent Study Showing Use of Vitamin E in Patients with Mild to Moderate Alzheimer Disease Slows Functional Decline

1/31/2014

For Immediate Release
Kelly Wavra
J.R. Carlson Laboratories, Inc.
600 W. University Drive, Arlington Heights, IL  60004
Tel. 847-255-1600  Fax: 847-255-1605
E-mail: kelly@carlsonlabs.com

 
Arlington Heights, IL ---January 2014--- Carlson Laboratories Reacts to Recent Study Showing Use of Vitamin E in Patients with Mild to Moderate Alzheimer Disease Slows Functional Decline. On January 1, 2014, The Journal of the American Medical Association (JAMA) published a study titled, “Vitamin E, Memantine, and Alzheimer Disease [sic].” The study results suggest the use of synthetic vitamin E—a daily dose of 2,000 IU— by patients with mild to moderate Alzheimer’s disease slows functional decline and reduces caregiver time in assisting.

A total of 613 patients with mild to moderate Alzheimer’s disease were chosen to determine the long-term safety and effectiveness of synthetic vitamin E, as dl-alpha tocopherol, and/or the effects of an acetylcholinesterase inhibitor called, memantine. While some subjects received only vitamin E or memantine, others received both the vitamin and the drug, or a placebo. Only the group solely taking vitamin E saw significant positive results. Alzheimer’s progression was delayed an average of 19% per year in the vitamin E group, while caregiver time was reduced by about two hours a day.

“Carlson Laboratories was happy to hear that vitamin E, the powerful antioxidant that initiated the start of our company, has been linked to a decline in the functional progression of Alzheimer’s patients,” said Carilyn Anderson, President of Carlson Laboratories. “Alzheimer's has been associated with oxidative stress, so it’s no wonder vitamin E is helpful in slowing this terrible disease. Carlson Laboratories began with one simple vitamin E formula in 1965. Since then, the line has grown to become the most complete line of natural-source vitamin E products in the world. Just two of our E-Gems Elite 1,000 IU soft gels provide 2,000 IU of natural vitamin E as alpha tocopherol. Further research of vitamin E and Alzheimer’s disease is needed, including a comparison of natural source vitamin E. Proven to be twice as active in our bodies as synthetic vitamin E, natural vitamin E may be even more beneficial for the brain.”

Return to Press Release Archive

Disclaimer: The statements and information upon this website have not necessarily been evaluated by the Food and Drug Administration. The products featured are not intended to diagnose, treat, cure or prevent any disease. Consumers should always consult their own medical practitioner(s) with any medical or health concerns before starting any new diet, product or supplement.